K KROMATID
Live / Allowed — Notice of allowance issued (as of 29 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99215716
- Mark type
- Design + words
- Filed
- 03 Jun 2025
- Published for opposition
- 04 Aug 2026
- Attorney of record
- Amanda H. Wilcox
Goods and services
- Class 001 — Chemicals: Assays and reagents for use in genetic research; Assays for research purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays for research purposes other than for medical or veterinary purposes; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific use; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use as reagents for scientific and research use in biotechnology fields; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for research purposes
- Class 005 — Pharmaceuticals: Cell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Cells for medical use; Clinical medical reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Immunoassay reagents for medical use; Culture media for cultivating human blood cells for diagnosing disease for medical purposes; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Stem cells for medical or veterinary use; Stem cells for medical purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs for medical purposes; Diagnostic preparations for medical purposes used by clinical or medical laboratories; Diagnostic reagents for medical purposes used by clinical or medical laboratories; Testing kits containing peptide substrates used in analyzing and detecting certain toxins used by clinical or medical laboratories
- Class 010 — Medical apparatus: Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing
- Class 035 — Advertising and business services: Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services
- Class 042 — Scientific and technological services: Custom design and development of chemical reagents and biochemical assays; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research in the field of oncology; Medical research services; Scientific research; Scientific research and development; Scientific research consulting; Scientific research in the field of genetics and genetic engineering; Genetic testing for scientific research purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research for medical purposes in the area of cancerous diseases
- Class 044 — Medical, beauty and agricultural services: DNA screening for medical purposes
Owner
- Kromatid Inc., LONGMONT, CO, US
- Kromatid Inc., LONGMONT, CO, US
Prior registrations
Prosecution history
- 29 Sept 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Aug 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Aug 2026 — PUBLISHED FOR OPPOSITION
- 29 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jul 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 29 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 31 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Oct 2025 — NON-FINAL ACTION E-MAILED
- 31 Oct 2025 — NON-FINAL ACTION WRITTEN
- 23 Oct 2025 — ASSIGNED TO EXAMINER
- 10 Oct 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED